Literature DB >> 16293682

Altered sleep regulation in leptin-deficient mice.

Aaron D Laposky1, Jonathan Shelton, Joseph Bass, Christine Dugovic, Nicholas Perrino, Fred W Turek.   

Abstract

Recent epidemiological, clinical, and experimental studies have demonstrated important links between sleep duration and architecture, circadian rhythms, and metabolism, although the genetic pathways that interconnect these processes are not well understood. Leptin is a circulating hormone and major adiposity signal involved in long-term energy homeostasis. In this study, we tested the hypothesis that leptin deficiency leads to impairments in sleep-wake regulation. Male ob/ob mice, a genetic model of leptin deficiency, had significantly disrupted sleep architecture with an elevated number of arousals from sleep [wild-type (WT) mice, 108.2 +/- 7.2 vs. ob/ob mice, 148.4 +/- 4.5, P < 0.001] and increased stage shifts (WT, 519.1 +/- 25.2 vs. ob/ob, 748.0 +/- 38.8, P < 0.001) compared with WT mice. Ob/ob mice also had more frequent, but shorter-lasting sleep bouts compared with WT mice, indicating impaired sleep consolidation. Interestingly, ob/ob mice showed changes in sleep time, with increased amounts of 24-h non-rapid eye movement (NREM) sleep (WT, 601.5 +/- 10.8 vs. ob/ob, 669.2 +/- 13.4 min, P < 0.001). Ob/ob mice had overall lower body temperature (WT, 35.1 +/- 0.2 vs. ob/ob, 33.4 +/- 0.2 degrees C, P < 0.001) and locomotor activity counts (WT, 25125 +/- 2137 vs. ob/ob, 5219 +/- 1759, P < 0.001). Ob/ob mice displayed an attenuated diurnal rhythm of sleep-wake stages, NREM delta power, and locomotor activity. Following sleep deprivation, ob/ob mice had smaller amounts of NREM and REM recovery sleep, both in terms of the magnitude and the duration of the recovery response. In combination, these results indicate that leptin deficiency disrupts the regulation of sleep architecture and diurnal rhythmicity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16293682     DOI: 10.1152/ajpregu.00304.2005

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  81 in total

1.  Neuropharmacology of Sleep and Wakefulness.

Authors:  Christopher J Watson; Helen A Baghdoyan; Ralph Lydic
Journal:  Sleep Med Clin       Date:  2010-12

Review 2.  Sleep and obesity: a focus on animal models.

Authors:  Vijayakumar Mavanji; Charles J Billington; Catherine M Kotz; Jennifer A Teske
Journal:  Neurosci Biobehav Rev       Date:  2012-01-16       Impact factor: 8.989

Review 3.  The Role of Circadian Rhythms in the Hypertension of Diabetes Mellitus and the Metabolic Syndrome.

Authors:  Björn Lemmer; Henrik Oster
Journal:  Curr Hypertens Rep       Date:  2018-05-05       Impact factor: 5.369

4.  Dysregulation of heart rhythm during sleep in leptin-deficient obese mice.

Authors:  Alessandro SilvanI; Stefano Bastianini; Chiara Berteotti; Carlo Franzini; Pierluigi Lenzi; Viviana Lo Martire; Giovanna Zoccoli
Journal:  Sleep       Date:  2010-03       Impact factor: 5.849

Review 5.  Fat circadian biology.

Authors:  Jeffrey M Gimble; Z Elizabeth Floyd
Journal:  J Appl Physiol (1985)       Date:  2009-05-21

6.  Percentage of REM sleep is associated with overnight change in leptin.

Authors:  Christy A Olson; Nancy A Hamilton; Virend K Somers
Journal:  J Sleep Res       Date:  2016-02-26       Impact factor: 3.981

7.  Diet/Energy Balance Affect Sleep and Wakefulness Independent of Body Weight.

Authors:  Isaac J Perron; Allan I Pack; Sigrid Veasey
Journal:  Sleep       Date:  2015-12-01       Impact factor: 5.849

Review 8.  Rev-erb-alpha: an integrator of circadian rhythms and metabolism.

Authors:  Hélène Duez; Bart Staels
Journal:  J Appl Physiol (1985)       Date:  2009-08-20

Review 9.  Circadian rhythms, sleep, and metabolism.

Authors:  Wenyu Huang; Kathryn Moynihan Ramsey; Biliana Marcheva; Joseph Bass
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

Review 10.  Sleep Duration and Diabetes Risk: Population Trends and Potential Mechanisms.

Authors:  Michael A Grandner; Azizi Seixas; Safal Shetty; Sundeep Shenoy
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.